Wang H, Jonas KJ, van de Vijver D. Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling study. J Acquir Immune Defic Syndr 2026 May 25. doi: 10.1097/QAI.0000000000003882.
PMID: 42184273